Seattle biotech heavy-hitters emerge from stealth with $46M for next-gen migraine treatments

https://cdn.geekwire.com/wp-content/uploads/2026/06/Vedana-Leadership.jpg" width="1024" />
Vedana Therapeutics emerged from stealth with a $46M Series A. Led by local biotech veterans, the Seattle startup is developing next-gen, at-home migraine injections. https://www.geekwire.com/2026/seattle-biotech-heavy-hitters-emerge-from-stealth-with-46m-for-next-gen-migraine-treatments/">Read More